|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/165 | (2006.01) |
| A61K 31/197 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 19/02 | (2006.01) | ||
| A61P 25/04 | (2006.01) |
| (11) | Patento numeris | 2682114 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13187396.0 |
| Europos patento paraiškos padavimo data | 2006-09-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-01-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 721722 P | 2005-09-28 | US |
| (72) |
Rao, Srinivas, G., US
Gendreau, Michael, US
Kranzler, Jay, D., US
|
| (73) |
Cypress Bioscience, Inc.,
4350 Executive Drive, Suite 325, San Diego, CA 92121,
US
|
| (54) | Milnacipran for the long-term treatment of fibromyalgia syndrome |
| Milnacipran for the long-term treatment of fibromyalgia syndrome |